Zabwino kwa Ogulitsa; Zovuta pa Zotsamba
Kuwonongedwa kwa chivomezi cha mankhwala osokoneza bongo sizinatchulidwe kuti "chigwa cha patent" ndi mafakitale amkati, anapitiriza kupyolera mu 2016. Mankhwala omwe adayambitsa $ 133 biliyoni ku US amalonda okha adzakhala ndi mpikisano wambiri, malinga ndi Evaluate Pharma. Zina mwa mankhwala ogulitsidwa kwambiri m'mbiri yakale chitayika chitetezo cha chivomezi mu 2011 ndi 2012. Mankhwala monga Lipitor, Plavix ndi Viagra anapindula mabiliyoni kwa othandizira awo pamene akuyika malonda padziko lonse.
Mankhwala Osokoneza Bongo Akupita Patsogolo 2013-2016
Mankhwala odchuka amayenera kutaya chitetezo cha msika wa US pakati pa 2013 ndi 2016:
2013
- Oxycontin (oxycodone HCI), opioid for management management, analandira $ 2.8 biliyoni pogulitsa mu 2011 kwa Purdue Pharma LP wopanga US.
- AcipHex (rabeprazole sodium), pofuna kupweteka kwa thupi pogwirizanitsa ndi matenda a asidi reflux, opanga: Eisai Inc. ndi Janssen Pharmaceuticals, Inc.
- Zometa (zoledronic acid) jekeseni ndi mankhwala a hypercalcemia a malignancy owopsa chifukwa cha khansa yapamwamba; Zaka 1,5 biliyoni zogulitsa malonda padziko lonse mu 2010. Zapangidwa ndi Novartis.
- Xeloda (capecitabine) ndi mankhwala am'kamwa amachititsa kansera yam'mimba yosalala ndi ya m'mawere yopangidwa ndi Genentech / Roche. Malonda a US akukula ndi maulendo awiri pachaka kukafika $ 647.6 miliyoni mu 2011.
- Opana ER (oxymorphone HCI), a agonist opioid adavomerezedwa kuti ayang'anire kupweteka kwambiri, opangidwa ndi Endo Pharmaceuticals Inc. Sales mu 2011 anali $ 384.7 miliyoni.
- Asacol (mesalamine), pochiza matenda a ulcerative colitis, adapeza ndalama zokwana madola 800 miliyoni pa malonda padziko lonse mu 2010. Wopanga: Warner Chilcott
2014
- Nexium (esomeprazole) yothandizira matenda a reflux a gastroesophageal (GERD) amapangidwa ndi AstraZeneca. Malonda a padziko lonse mu 2010 anali $ 4.9 biliyoni.
- Cymbalta (duloxetine HCI), lopangidwa ndi Eli Lilly, ndiwothandizira kuvutika maganizo, matenda osokonezeka maganizo, matenda a shuga a mitsempha, fibromyalgia ndi ululu wamisala. Kugulitsa kwapadziko lonse kunadutsa $ 4 biliyoni mu 2011.
- Celebrex (celecoxib) ndizochiza matenda a osteoarthritis ndi matenda a nyamakazi a nyamakazi komanso kusamalira ululu waukulu kwa akuluakulu. Pfizer, yemwe amapanga zinthuzo, anagulitsa malonda a $ 2.5 biliyoni mu 2011.
- Symbicort (budesonide / formoterol fumarate dihydrate) ya mphumu ndi COPD imapangidwa ndi AstraZeneca. Malonda a Symbicort anali $ 3.1 biliyoni mu 2011.
- Lunesta (eszopiclone), chithandizo cha kusowa tulo, amapangidwa ndi Sunovion Pharmaceuticals Inc., yothandizidwa ndi Dainippon Sumitomo Pharma Co. Ltd. Malonda onse mu 2010 anali $ 631 miliyoni.
- Restasis (cyclosporine ophthalmic emulsion) chifukwa cha kuchuluka kwa misozi kwa odwala omwe ali ndi maso ouma, amapangidwa ndi Allergan. Mu 2010, malonda padziko lonse anafika $ 621 miliyoni.
- Evista (raloxifene HCI), lopangidwa ndi Eli Lilly, ndilokuchiza ndi kupewa matenda osteoporosis. Evista analandira malonda okwana madola 1.3 biliyoni mu 2010.
- Sandostatin LAR (octreotide acetate kwa kuyimitsidwa kwa jekeseni) ndi Novartis, ndiyo njira yothandizira matenda a acromegaly, matenda a mahomoni, ndi kutsegula m'mimba komanso kuthamanga komwe kumayambitsidwa ndi khansa ya m'magazi. Malonda a padziko lonse anali $ 1.3 biliyoni mu 2010.
- Actonel (risedronate) ndiwothandiza kupewa ndi kuchiza matenda a mitsempha. Mu 2010, malonda padziko lonse anali $ 1.6 biliyoni. Actonel amapangidwa ndi Warner Chilcott.
2015
- Kupatsa mphamvu (aripiprazole) ndi Otsuka Mankhwala ndi anti-psychotic yogwiritsidwa ntchito pochiza zizindikiro za matenda a schizophrenia ndi matenda a bipolar. Mu 2010, malonda padziko lonse anafikira $ 4.6 biliyoni.
- Copaxone (jekeseni ya acetate jekeseni) ndi mankhwala a kubwezeretsa-kutulutsa multiple sclerosis (RRMS) opangidwa ndi Teva Pharmaceuticals. Malonda anafika $ 3.57 biliyoni mu 2011.
- Gleevec (imatinib mesylate) ndi mankhwala odwala matenda a myeloid (CML) ndi chifuwa cha m'mimba (GIST). Malonda a padziko lonse anali $ 4.26 biliyoni mu 2010. Gleevec amapangidwa ndi Novartis.
- Namenda (mememine HCI) ndi mankhwala ochepetsa matenda oopsa a Alzheimer omwe amapangidwa ndi Forest Laboratories, Inc.
- Provigil (modafinil), chithandizo cha kugona kwambiri ndi kusinthasintha matenda ogona, chimapangidwa ndi Teva Pharmaceuticals. Chogulitsacho chinapanga $ 350 miliyoni pa malonda mu 2011.
- Mbalame (albuterol ndi ipratropium inhalation) ndi kasamalidwe ka zizindikiro za matenda obisala m'mimba (COPD). Boehringer Ingelheim anafotokoza malonda a $ 965 miliyoni mu 2010.
- Zyvox (linezolid) ndi mankhwala oletsa tizilombo opangidwa ndi Pfizer. Kampaniyo inalengeza za malonda a $ 325 miliyoni mu 2011.
- Prezista (darunavir) ndi protease inhibitor kwa kachilombo koyambitsa matenda a munthu. Kufalitsidwa ndi Janssen Therapeutics, Prezista malonda anali $ 888 miliyoni padziko lonse mu 2010.
- Avodart (dutasteride) ndi mankhwala a benign prostatic hyperplasia (prostate gland yowonjezera). GlaxoSmithKline adawonetsa ndalama za $ 973 miliyoni padziko lonse lapansi 2010.
2016
- Crestor (rosuvastatin calcium) ndi Astra Zeneca, ndi mankhwala ochepetsa LDL cholesterol I magazi. Crestor malonda anali $ 6 biliyoni mu 2010.
- Benicar (olmesartan medoxomil) ya kuthamanga kwa magazi imapangidwa ndi Daiichi Sankyo, Inc. Mu 2010, malonda anali $ 2.5 biliyoni.
- Cubicin (daptomycin) ndi anti-viral yopangidwa ndi Cubist Pharmaceuticals. Ndalama zomwe zinapangidwa ndi madola 644 miliyoni pa malonda padziko lonse mu 2010. Mankhwala ochiritsira, datomyucin, adavomerezedwa pa July 6, 2016.
- Zetia (ezetimibe) amagwiritsidwa ntchito pochiza mafuta ambiri a cholesterol, opangidwa ndi Merck.
- Nuvigil (armodafinil) amagwiritsidwa ntchito pochita tulo zokhudzana ndi narcolepsey ndi kugona tulo. Yopangidwa ndi Teva.
- Intuniv (guanfacine hydrochloride) amagwiritsidwa ntchito popanga ana ADHD, opangidwa ndi Shire.
- Seroquel XR (quetiapine fumarate) amagwiritsidwa ntchito popanga mankhwala ovutika maganizo, opangidwa ndi AstraZeneca.
Inde, pali zinthu zambiri zomwe zingawonongeke pamene kampani yowonjezera ikuyesa kupanga pulogalamu yatsopano kumsika wogonjetsa.
Zotsatira
EvaluatePharma Ltd. Makampani azachipatala akugwedeza maulamuliki a mbiri Zokonzera, ZongerezaniZomwe dera likuwonekera. February 2, 2011.
IMS Health
Malipoti a kampani